I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) stock fell 1.20% to $439.95, outperforming competitors UnitedHealth Group and Cigna during a rough trading session where the S&P 500 and Dow Jones also declined. ELV closed 2.38% below its 52-week high. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) slid 1.20% to $439.95 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,623.68 and Dow Jones Industrial Average falling 1.23% to 52,215.16.
Elevance Health Inc. closed 2.38% below its 52-week high of $450.69, which the company reached on October 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as UnitedHealth Group Inc. (UNH) fell 1.62% to $418.09, Cigna Group (CI) fell 2.83% to $306.95, and Humana Inc. (HUM) rose 0.26% to $422.07.
Trading volume (1.1 M) remained 28,751 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-23-26 1640ET